Industry News
Potential to predict lung-cancer spread via MicroRNA-31
Sep 26, 2013
Determining whether a patient's lung cancer has spread to nearby lymph nodes is critical for identifying the most effective therapy, but it usually requires surgery. A new study suggests, however, that measuring levels of a particular molecule in a sample of tumor tissue might accurately answer the question. Researchers at The Ohio State University Comprehensive Cancer Center - Arthur G... Read More
Growing number of young adults with oropharyngeal cancer linked to HPV
Sep 26, 2013
The human papillomavirus (HPV) may be to blame for the alarming increase of young adults with oropharyngeal cancer, according to researchers from Henry Ford Hospital in Detroit. The study reveals an overall 60 percent increase from 1973 and 2009 in cancers of the base of tongue, tonsils, soft palate and pharynx in people younger than age 45... Read More
Biological risk factor pinpointed in obesity-related cancers
Sep 26, 2013
It is estimated that over a third of the new cancer cases expected to occur in the U.S. in 2013 will be related to overweight or obesity, physical inactivity, and poor nutrition. Thanks to the work of one NYU Steinhardt researcher, we may better understand why... Read More
Diarrhea not reduced by sulfasalazine in patients receiving radiation therapy
Sep 26, 2013
Sulfasalazine, a drug commonly prescribed to reduce diarrhea in patients with inflammatory bowel disease, does not reduce diarrhea in patients receiving radiation therapy for cancers in the pelvic area a Mayo Clinic-led study has found. The study also found that the medication may be associated with a higher risk of diarrhea than a placebo when used during radiation therapy to the pelvis... Read More
Renal problems a greater risk for some childhood cancer survivors
Sep 26, 2013
Adult survivors of childhood cancers who underwent certain chemotherapy treatments or kidney surgery had worse kidney function that did not recover over time. Because of this, they may be at higher risk for premature renal failure, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research... Read More
Mortality risks not increased by external beam RT in early-stage breast cancer
Sep 26, 2013
Early-stage breast cancer patients who receive external beam therapy (XRT) are not at higher risk for serious long-term side effects in the chest area, including increase in deaths from cardiac disease and secondary malignancies, according to research presented at the American Society for Radiation Oncology's (ASTRO's) 55th Annual Meeting... Read More
USC scientists ID protein that regulates cellular trafficking, potential for anti-cancer therapy
Sep 25, 2013
Molecular microbiologists at the Keck School of Medicine of the University of Southern California (USC) have uncovered intricate regulatory mechanisms within the cell that could lead to novel therapeutics for the treatment of cancer and other diseases. Their findings, which have long-standing significance in the basic understanding of cell biology, appear in the journal Nature Cell Biology... Read More
Long-term hormonal therapy in intermediate-risk prostate cancer patients does not improve overall survival
Sep 25, 2013
A secondary analysis of the historic RTOG 9202 prostate cancer trial examined results of men with intermediate-risk prostate cancer who had received long-term hormonal therapy after radiation therapy, and concluded that there were no additional benefits when compared to short-term hormonal therapy, according to research presented today at the American Society for Radiation On... Read More
New treatments aim to combat renal cell cancer and melanoma
Sep 25, 2013
Renal cell cancer vaccines Immatics Biotechnologies' cancer vaccine IMA901 is currently in phase III trials for the first-line treatment of metastatic renal cell cancer. The drug, which was shown to have a positive safety profile in its single-arm Phase II trial, is expected to gain approval in the US and five major EU markets* by 2015... Read More
Patient-reported outcomes provide valuable insight regarding quality of life for patients with non-small cell lung cancer
Sep 25, 2013
An analysis of quality of life (QOL) data of stage III lung cancer patients who received higher doses of radiation therapy (with chemotherapy) shows a significantly lower quality of life at 3 months after treatment compared to patients who received a standard dose of radiation (with chemotherapy), according to research presented at the American Society for Radiation Oncology's ... Read More
Previous Page Next Page